Therese Bittermann, MD, MSCE
Assistant Professor of Medicine (Gastroenterology) at the Hospital of the University of Pennsylvania
Department: Medicine
Contact information
Hospital of the University of Pennsylvania
Penn Transplant Institute
2 Dulles
3400 Spruce Street
Philadelphia, PA 19104
Penn Transplant Institute
2 Dulles
3400 Spruce Street
Philadelphia, PA 19104
Office: 215-349-8222
Fax: 215-349-5915
Fax: 215-349-5915
Education:
BA (Biological Sciences; International Studies)
Northwestern University, 2005.
MS (Physiology and Biophysics)
Georgetown University, 2006.
MD (Medicine)
Drexel University College of Medicine, 2010.
MS (Clinical Epidemiology)
University of Pennsylvania, 2017.
Permanent linkBA (Biological Sciences; International Studies)
Northwestern University, 2005.
MS (Physiology and Biophysics)
Georgetown University, 2006.
MD (Medicine)
Drexel University College of Medicine, 2010.
MS (Clinical Epidemiology)
University of Pennsylvania, 2017.
Description of Clinical Expertise
I care for patients with viral hepatitis, auto-immune diseases of the liver, fatty liver disease, liver tumors, and cirrhosis. I also have expertise in pre- and post-transplantation management.Description of Research Expertise
I study the relationship between immunosuppression strategy and outcomes after liver transplantation. I have previous expertise in research related to organ allocation, the effects of transplant policy-making and center variability in patient care. I also have research interests in autoimmune hepatitis and alcohol-associated liver disease. I have an advanced degree in clinical epidemiology, and have expertise with observational study designs, large databases and statistics.Selected Publications
Durkin C, Bittermann T: Liver transplantation for alcohol-associated hepatitis. Current Opinion in Organ Transplantation 28(2): 85-94, Apr 2023.Ibeabuchi T, Li E, Bittermann T, Mahmud N, Abt PL: Can ex-situ normothermic perfusion improve graft survival compared to static cold storage among donation after circulatory death liver allografts? Liver Transplantation Epub ahead of print, Apr 2023.
Kathawate RG, Abt PL, Bittermann T: Center expansion of liver transplants using donation after circulatory death organs is associated with reduced overall waitlist mortality. Clinical Transplantation Epub ahead of print, Mar 2023.
Liapakis A, Agbim U, Bittermann T, Dew MA, Deng Y, Gan G, Emre S, Hunt HF, Olthoff KM, Locke JE, Jesse MT, Kumar V, Pillai A, Verna E, Lentine KL: A survey of transplant providers regarding attitudes, barriers, and facilitators to living donor liver transplantation in the United States. Clinical Transplantation Epub ahead of print, Mar 2023.
Liapakis A, Jesse MT, Pillai A, Bittermann T, Dew MA, Emre S, Hunt H, Kumar V, Locke J, Mohammad S, Olthoff K, Verna EC, Lentine KL; LDLT Consensus Working Group: Living donor liver transplantation: A multi-disciplinary collaboration towards growth, consensus, and a change in culture. Clinical Transplantation Epub ahead of print, Mar 2023.
Wood P, Huang YS, Sanchez L, Kitt E, Abt PL, Bittermann T: The effectiveness and safety of antibody induction immunosuppression in a large cohort of United States pediatric liver transplant recipients. American Journal of Transplantation Epub ahead of print, Mar 2023.
Lentine KL, Tanaka T, Xiao H, Bittermann T, Dew MA, Schnitzler MA, Olthoff KM, Locke JE, Emre S, Hunt HF, Liapakis A, Axelrod DA: Variation in adult living donor liver transplantation in the United States: Identifying opportunities for increased utilization. Clinical Transplantation Epub ahead of print, Feb 2023.
Bittermann T, Mahmud N, Weinberg EM, Reddy KR: MELD 3.0 leads to heterogeneous prioritization of men and women on the liver transplant waiting list. Liver Transplantation Epub ahead of print, Feb 2023.
Kathawate RG, Ibeabuchi T, Abt PL, Bittermann T: Utilization and outcomes of rescue hepatectomy among U.S. liver retransplant candidates. Clinical Transplantation Epub ahead of print, Feb 2023.
Durkin C, Schaubel DE, Xu Y, Mahmud N, Kaplan DE, Abt PL, Bittermann T: Induction Immunosuppression Does Not Worsen Tumor Recurrence After Liver Transplantation for Hepatocellular Carcinoma. Transplantation Epub ahead of print, Jan 2023.